Stock Review : Federal Bank – An old private bank learning new tricks

In these reviews, we pick stocks that have rallied, or where businesses are interesting or changing, or where companies may be relatively unknown and so on. We present an analysis of these stocks, covering what has driven them, business prospects, threats and more. These reviews are meant to give you an understanding of a stock. They are not our recommendations.

One set of financial stocks that haven’t participated in the recent bull market are old private sector bank stocks. Traditional industrial lending has gone through a rough patch in recent years and regional banks that have catered to specific communities or regional niches while staying true to old-world lending have faced a lot of challenges.

While three banks in this space have floundered (Nedungadi Bank, Lord Krishna Bank and Lakshmi Vilas Bank) and seven have survived, only City Union Bank (CUB) has created meaningful shareholder value in the last decade through a laser focus on asset quality and conservative lending. Federal Bank is charting a different course with a significant thrust on technology, digital adoption and diversification into new retail segments in the last five years.

federal bank, federal bank review, federal bank stock review, stock review

The business

Federal Bank is an old private sector bank with 100% public ownership and professional management. The bank’s business mix has remained largely the same over a decade with corporate, agriculture, SME and conventional retail loans like home, vehicle and gold loans. In recent years, the cost-to-income ratio has spiked above 50% and that has led to poor Return on Equity (RoE) since FY16. Apart from a branch expansion spree, traditional work culture and resistance to change dragged the bank from pursuing cross selling opportunities. 

But there are bright spots emerging. The bank has put its branch expansions on hold since FY16. It has been investing significantly in technology in the last five years and the benefits are becoming visible in terms of the scale of digital transactions, loan originations, enhanced utilization of credit in e-commerce and merchant purchases and ability to quickly partner with fintech start-ups. With RoE improving in the last two years and a likely rebound in economic activity, the bank appears to have multiple tail-winds to return to growth with better RoE going forward.

Federal Bank has a 74% NBFC subsidiary Fedbank Financial Services focused on gold loans, small and medium ticket loan against property (LAP) and small business loans. The subsidiary ended Q1FY22 with a book size of Rs.4,712 crore and net profit of Rs. 15 crore. Asset quality deteriorated sharply in Q1FY22 with gross and net NPAs rising to 3.21% and 2.68%, respectively. Capital adequacy is however strong at 26.9%,  

The bank also has 26% stake in Ageas Federal Life Insurance which was earlier IDBI Federal Life Insurance.  Belgian insurer Ageas Insurance International bought a 23% stake from IDBI and the entity has been re-named.  IDBI Bank still holds 25% stake in the life insurer, while Ageas holds 49%. There is scope for further acquisition of shares by the foreign partner pursuant to approval of 74% FDI in life insurance. Federal Bank also holds a 19.90% stake in Equirus Capital which operates in the areas of investment banking, wealth management and insurance broking. The subsidiaries and associates of the bank are at early stages in their growth cycles and so do not meaningfully contribute to valuation at this point of time.  

The bank’s positives are as follows.

#1 Pegged to the economic cycle

Economic growth is the strongest tail-wind for traditional banks like Federal Bank given that loan growth in the corporate and Small & Medium Enterprise (SME) segments is directly linked to GDP expansion. Federal Bank had a loan mix of 54:46 on corporate and retail loans in Q1 FY22. In the last decade, credit growth for Indian banks has decelerated from ~20% to ~5% as the capex boom petered out and nominal GDP growth slowed. The global financial crisis and domestic scams which led to stuck infrastructure projects, set off de-leveraging by industrial sectors and triggered a shakeout among India’s traditional industrial groups.  

Here’s how bank loan growth panned out in India in the last 10 years

Federal Bank had its own share of woes. After a massive branch expansion spree between FY12 to FY16 which doubled its network, the bank had an elevated cost-to-income ratio that brought down its RoE. But it has put branch expansion plans on the hold for the last four years , with 1272 branches at the end of FY21, not much higher than in FY16. The bank has also gone through significant asset quality challenges during this period. The stressed assets book of the bank was at 4.3% in the beginning of FY16 and continuously came down to 1% in Q2FY21, before rising past 2% in Q1FY22 in the aftermath of the pandemic. Covid has aggravated corporate risk aversion and consequently, credit growth both towards project and working capital lending has slipped further. 

But post Covid, prospects are bright for both working capital and project lending to revive. Ultra-low interest rates, low corporate tax rates and production linked incentives (PLI) for capex, not to talk of the recent revival in the commodity cycle and governments globally focusing more on infrastructure building as stimulus, could prove a turning point for industrial lending and banks engaged in it. Federal Bank, even though it managed to grow its advances at 8% in FY21 saw corporate advances de-grow by 4%. A revival in industrial activity and a resumption of the capex cycle and resultant credit demand will trigger a growth cycle for traditional banks such as Federal Bank.   

Following is the segment wise break-up of advances of the bank

#2 Technology, collaboration

The key strength of traditional banks such as Federal Bank is a loyal and large customer base, but unlike leading private sector banks missed the bus on cross-selling and stayed away from the high yielding retail lending business. With the downturn in industrial lending, their RoAs and RoEs have drifted down. But Federal Bank has been ahead of its counterparts in making timely investments in digital technologies, with good collaborations. The bank was quite early to flag off innovations such as the Selfie Account and mobile banking. It started investing in open banking from 2017 and is recognized as a strong player with more than 83 APIs and 13 API bundles and 100+ partners connected to the platform.  

Below is a list of tie-ups Federal Bank has forged with various Fin-tech players in open banking

federal bank, federal bank open banking

Source: Federal Bank Q4FY21 Presentation

The bank has also become the top partner for Bharat Pe, processing 1.5 million transactions a day and serving 3.7 million merchants on its platform. The bank’s own mobile platform in digital personal loans has succeeded and it has capitalised on debit card spends in e-commerce and POS terminals, with an EMI option.  Transactions in its omni-channel platform for corporates crossed Rs 10,000 crore in Q4FY21. This will be a key space to watch out for as the efforts of the last many years are coming to fruition.

#3 New high yielding segments to aid returns

Federal Bank has a strong deposit franchise with Current & Savings (CASA) at 34.81% by Q1FY22. It has identified credit cards, commercial vehicle (CV) finance and microfinance as the new segments for future growth. It kick-started the CV finance segment last year and closed FY21 with total book size of Rs. 912 crore registering a growth of 58% with a mix of new and used CVs. Micro-finance segment is still small with a book size of Rs.300 crore and is looking to expand both organically and in-organically. Federal Bank has rolled out cards for its employees on a pilot basis, but the MasterCard issue may delay the roll out by a few months.  The bank is initially targeting up to 10% of its own customer base of 1.1 crore customers for credit cards. 

To put this in perspective, RBL Bank with a book size of Rs. 58,000 crore has a credit card base of 2.96 million contributing to 21% of its advances while for IndusInd, the micro-finance portfolio is around 13% of its advances. IndusInd Bank’s blended yield was 11.78% in FY21 with the corporate segment at 8.42% and consumer segments including CV loans and microfinance at 14.27%. 

The management has maintained that it will move slowly and steadily in these new segments in the aftermath of COVID and scale up in the next 2-3 years. Federal Bank has enough headroom to grow in the new segments and improve its return ratios.

#4 Asset quality, no negative surprises

Federal Bank closed FY21 on a decent note despite asset quality deterioration which was within the management guided limits. Gross and Net NPA were at 3.41% and 1.19% respectively while the re-structured book due to Covid was at 1.04%. The bank maintained provision coverage at 65% at the end of FY21 and the stressed assets book was at 1.76% at the end of FY21 contributed by Covid related restructuring. The stressed assets book of the bank had been continuously declining from the peak of 4.3% in FY16 to 1.3% at the end of FY20 before Covid. RoA has moved past 1% in Q4FY21 and RoE has topped the 12% mark.  

The bank has started FY22 with some increase in restructured loans to 2.24% in Q1FY22 from 1.76% at the end of FY21, while Covid specific re-structuring increased to 1.82%.  There was Rs.200 crore of re-structuring from the gold loan portfolio as well while the Loan to value (LTV) ratio stands at 74%. This book may be susceptible to more NPAs in Q2 from incremental loans given out in FY21.

Gross and Net NPAs have inched up marginally to 3.5% and 1.23% respectively while provision coverage has been maintained at 65%. It has used treasury windfalls and loan recoveries to boost provisions, which increased 89% compared to the previous quarter.

Peer comparison

While Federal Bank is still seen as a mid-sized old private sector bank, its technology initiatives distinguish it and it has been regarded as one among the top private sector banks in this area. The bank has also attained significant business size to be categorized among top private banks. But it still lags in some core areas affecting valuations. Yield on advances and lower cost-to-income ratio are the key areas on which the bank needs to deliver to enhance RoA and RoE.  

Below is a comparison of the bank with old regional private banks as well as some new private banks.

Key risks

#1 Dependence on NRI deposits

Federal Bank has high dependence on NRI deposits that make up ~40% of its total deposits and form a significant source of low-cost funds. Current and savings account deposits (CASA) stood at 34.8% at the end of Q1FY21 Vs 33.8% in FY21 while the ratio was at 30.5% in FY20. The churn in the Middle Eastern economies recently has resulted in a returning immigrant flow and World bank predictions indicate a reduction in inbound remittances. While remittances remained strong in CY20 with a drop of just 0.2% over CY19, the trend in CY21 needs to be closely watched for any clear picture. Any disruption in this source of Federal Bank’s CASA could have an impact on cost of funds which will in-turn impact the RoA and RoE trajectory.  The bank’s share in remittances stood at 18.2% in Q1FY22 Vs 16.5% at the end of FY21.

#2 Low CAR, though adequate

Federal bank’s capital adequacy ratio (CAR) stood at 14.64% at the end of Q1FY22 with Tier 1 at 13.87%. The board has also allotted 10.48 crore shares to IFC at Rs. 87.39 per share on July 23, 2021. This could boost its CAR to 15.5%. Tier 2 capital stands at 0.77%. But still the bank seems to have a low CAR compared to many of its peers. If asset quality deteriorates further, CAR will need further shoring up.  The bank is still looking to boost its capital structure further in FY22 through equity and debt issuances and can expect a further 5% equity dilution later.

#3 Dependence on management

Unlike other old private sector banks which have seen management ousters and disputes, Federal Bank has been a beneficiary of stable management. The present CEO Mr. Shyam Srinivasan has been at the helm for 11 years and his tenure has been extended recently by RBI until September 2024. The bank has appointed Ms Shalini Warrier as Executive Director in January 2020 with succession in mind. Any disruption to this transition can create uncertainties about the bank’s return to growth and go-to-market strategy.

#4 Asset quality risk

High yielding loan segments come with commensurate risk. The post Covid period may be a dicey time for any traditional lender to expand its footprint into higher yielding retail or unsecured segments that carry higher default risks. Recent financials from lenders in these segments suggest a spike in NPAs in vehicle and unsecured retail loans. Building strong under-writing skills remains the key in areas like CVs, credit cards and micro-finance. Federal Bank’s ability to make headway in these segments without asset quality slippages needs to be closely watched.

#5 Fintech threat

New-age fintech firms making forays into peer-to-peer lending, payments and mobile wallets are feared to cause disruption to traditional banks, as the former can scale up without significant investments in branch banking or personnel. While universal banks do have limited scope for micro-segmenting customers, fintech players are more likely to emerge as collaborators rather than disruptors for banks. Federal Bank has made significant progress on technology adoption in corporate banking with full solutions for payment processing, pay-roll processing, supply chain management, trade finance, and receivables & payment management.  

So far in India, the fintech revolution has focused more on payments until now and has not made a big dent in the banking business. Payments as a business is also not making money for most players. On the other hand, banking is a commoditized money-making machine when the assets and liabilities are well-managed. 

While neo-banks are looking to change the way banking is done, they are not standalone banks and operate by plugging into existing bank APIs. Therefore, banks may remain as the trusted source of finance while fintech firms may be their collaborators rather than disruptors.  Collaborations look to be the way forward with a significant thrust on API /open banking. Federal Bank has had a head start on this strategy.

Valuation

At Rs. 87, the Federal Bank stock is trading at about ~1 time its FY21 book value. The stock has mostly traded in the 1 to 1.5 times price to book value band in the last 10 years primarily due to its sub-par RoE. Now, the bank seems to be moving in the right direction by diversifying into high yield lending and partnering with fin-tech. While resumption of the economic growth cycle will itself act as a key tail-wind for traditional banks, the ability to enter into and succeed in high yielding lending areas will determine the extent of valuation re-rating. With RoA crossing 1% mark in Q4 FY21 and RoE moving to 12%, whether the bank gets back to its own peak RoA and RoE levels of 1.4 -1.5% and 14 -15% respectively in the next few years, will be the key factors to watch for a re-rating.

More like this

1 thought on “Stock Review : Federal Bank – An old private bank learning new tricks”

Comments are closed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free